Digital Health News | pharmaphorum

News

Insilico ends 2025 with $293m Hong Kong IPO

One of the pioneers in AI-powered drug discovery, Insilico Medicine, has completed an oversubscribed IPO in Hong Kong, raising around $293m.

News

Chai raises $130m for AI drug discovery platform

AI specialist Chai Discovery has said it is sitting on a valuation of around $1.3 billion, after raising $130 million in a Series B financing.

News

Raymond Chua of Singapore's Health Sciences Authority and Lawrence Tallon of the UK Medicines and Healthcare products Regulatory Agency.

UK teams up with Singapore on healthtech regulation

A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.

News

Woman wears neuro headset for depression

FDA clears first at-home device for depression

Flow Neuroscience has secured FDA approval for FL-100, the first at-home brain stimulation device for major depressive disorder.

News

Hims & Hers launches weight-loss business in UK

Hims & Hers has launched its direct-to-consumer weight-loss therapy channel in the UK, offering Wegovy, Mounjaro, and OTC option Orlos.

News

Lab-in-a-loop specialist Relation attracts Novartis alliance

UK-based AI and multi-omics company Relation Therapeutics will seek out targets for allergic diseases on behalf of Novartis in a $1.7bn-plus alliance.

Insilico ends 2025 with $293m Hong Kong IPO

Chai raises $130m for AI drug discovery platform

UK teams up with Singapore on healthtech regulation

FDA clears first at-home device for depression

Hims & Hers launches weight-loss business in UK

Lab-in-a-loop specialist Relation attracts Novartis alliance

Pharvaris plans filings for HAE drug after pivotal trial win

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks